← Eichor
Study identifier: NCT06025734 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder

Condition: Spina Bifida  ·  Sponsor: University of Texas Southwestern Medical Center

PhaseNA
Planned participants12
Who can joinAll sexes, 8 Years to 18 Years
Healthy volunteersNo

About this study

The purpose of this research study is to determine the effectiveness of a treatment called "transcutaneous tibial nerve stimulation" or "TTNS" in the treatment of urinary leakage for patients with spina bifida. This treatment involves electrical stimulation of a nerve by the ankle. Participants will complete urodynamic testing and questionnaires prior to the treatments. Participants will then complete 6 weekly treatments of TTNS. Participants will learn how to do the treatment in the clinic, and then can complete the treatments at home. For patients with a good response, the treatments may be continued for another 6 weeks, for a total of 6 weeks.

This description comes directly from the study's public registry record.

Talk to the study team

Alexandra Carolan, MD  ·  214-456-5632  ·  alexandra.carlon@utsouthwestern.edu

Shreedhar Reddy  ·  shreedhar.reddy@utsouthwestern.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Scottish Rite for ChildrenDallas, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06025734